Loading…
Solara Active Pharma Sciences (SOLARA)₹648.05−0.99%Pharmaceuticals
At the end of the Sep 2026 quarter, Solara Active Pharma Sciences' shareholders were: promoters 41.98%, FIIs 10.69%, DIIs 3.92%, public 43.41%. Promoter holding is unchanged on the quarter. FII holding is down 2.87 percentage points from 13.56% a year earlier. 51.99% of promoter shares were pledged. It had 70,902 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 30.54% | 30.54% | 37.32% | 37.32% | 37.28% | 37.99% | 42.06% | 42.06% | 42.05% | 42.05% | 41.98% | 41.98% |
| FIIs | 16.60% | 15.78% | 13.98% | 14.23% | 14.65% | 14.61% | 14.23% | 13.56% | 11.96% | 11.57% | 11.50% | 10.69% |
| DIIs | 1.76% | 3.00% | 2.85% | 3.40% | 3.22% | 2.63% | 2.64% | 2.71% | 3.67% | 3.78% | 3.77% | 3.92% |
| Public | 51.10% | 50.68% | 45.85% | 45.05% | 44.85% | 44.77% | 41.07% | 41.67% | 42.32% | 42.60% | 42.75% | 43.41% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 51.99% |
| Number of shareholders | 72,915 | 73,909 | 77,167 | 71,879 | 83,145 | 75,788 | 74,331 | 72,476 | 71,887 | 70,397 | 70,487 | 70,902 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Devicam Capital Llp | Promoter | 15.52% | 0.00 |
| Pronomz Ventures Llp | Promoter | 9.66% | 0.00 |
| Authum Investment And Infrastructure Limited | Public | 3.79% | 0.00 |
| Spiracca Ventures Llp. | Public | 3.51% | 0.00 |
| Srjr Enterprise Llp | Promoter | 3.51% | 0.00 |
| Arun Kumar Pillai | Promoter | 3.47% | 0.00 |
| K R Ravishankar | Promoter | 2.73% | 0.00 |
| Hbm Healthcare Investments (Cayman) Ltd | FII | 2.19% | 0.00 |
| Chayadeep Ventures Llp | Promoter | 2.12% | 0.00 |
| Agnus Capital Llp | Promoter | 1.75% | 0.00 |
| Mauryan India Fund | DII | 1.63% | +0.27 |
| Route One Offshore Master Fund, L.P. | FII | 1.45% | 0.00 |
| The Scottish Oriental Smaller Companies Trustplc | FII | 1.43% | −0.89 |
| Raptakos, Brett And Co. Ltd. | Public | 1.32% | −0.05 |
| Fssa Indian Subcontinent Fund As Sub Fund Of First Sentier Investors Global Umbrella Fund Plc | FII | 1.17% | −0.64 |
| Chayadeep Properties Private Limited | Promoter | 1.10% | 0.00 |
| Agraganya Private Trust (Trustee: Barclay Wealth Trustees (I) Pvt Ltd) | Promoter | 1.09% | 0.00 |
| Turnaround Opportunities Fund | DII | 1.00% | 0.00 |
| Karuna Business Solutions Llp | Promoter | 0.14% | 0.00 |
| Deepa Arun Kumar | Promoter | 0.12% | 0.00 |
| Aditya Arun Kumar | Promoter | 0.11% | 0.00 |
| Padmakumar Karunakaran Pillai | Promoter | 0.11% | 0.00 |
| Sajitha Pillai | Promoter | 0.11% | 0.00 |
| Tarini Arun Kumar | Promoter | 0.11% | 0.00 |
| Hemalatha Pillai | Promoter | 0.09% | 0.00 |
Promoters held 41.98% of Solara Active Pharma Sciences at the end of the Sep 2026 quarter, down 0.08 percentage points from 42.06% a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 10.69% (down 0.81 percentage points from 11.50% a quarter earlier) and domestic institutions (DIIs) held 3.92% (up 0.15 percentage points from 3.77% a quarter earlier).
Yes. 51.99% of promoter shares were pledged at the end of the Sep 2026 quarter.
Solara Active Pharma Sciences had 70,902 shareholders at the end of the Sep 2026 quarter, against 72,476 a year earlier.
Authum Investment And Infrastructure Limited (Public) held 3.79% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.